News

Filter news by
Researchers improve simulation of shockwaves
Zurich - Researchers at the Swiss Federal Institute of Technology Zurich have found a way to simulate highly turbulent flows. To do so, they used new theoretical approaches as well as the Piz Daint supercomputer.
Zurich takes top spot in Smart City Index 2023
Lausanne/Singapur - Zurich has topped the global IMD Smart City Index 2023 for the fourth consecutive time. The ranking uses diverse criteria to measure how smart a city is according to its citizens. Of the 141 cities surveyed, Lausanne scooped 5th and Geneva 9th place.
ETH establishing medical research site in Schlieren
Zurich/Schlieren - The Swiss Federal Institute of Technology in Zurich (ETH) is developing a leased site in Schlieren into a laboratory for its medical research. The proximity to partners and some of its spin-offs in the Bio-Technopark Schlieren-Zurich will promote the transfer of research to practical application.
PostFinance partners with digital bank Sygnum
Bern/Zurich - PostFinance is to leverage Sygnum’s B2B banking platform and will now offer its customers a range of regulated digital asset banking services. The financial services unit of Swiss Post is thereby meeting a customer investment need uncovered through a market analysis.
Moflix ranks among the world’s leading providers of eSIM technology
Wollerau/Hong Kong - The start-up Moflix is ranked in second place globally for embedded SIM (eSIM) technology. According to an international market analysis, the start-up, which was founded in 2019, is therefore among the main challengers to the market leader, the US firm Amdocs.
Infotech building new headquarters in Grenchen
Solothurn/Grenchen - The Solothurn-based plant manufacturer Infotech will start building its new headquarters in Grenchen on April 5. The high-tech firm is set to more than double its office and assembly space at the new site. The sustainable building is being constructed by SSM Architects from Solothurn.
Cutiss presents results from two successful studies
Schlieren - Cutiss has presented the results of two studies investigating its skin substitute product denovoSkin. The safety of the product was demonstrated in the Phase 1 trial in children, while efficacy was the focus of the clinical Phase 2 trial.
ZEISS invests in InSphero
Schlieren/Oberkochen - InSphero has received an eight-figure investment from ZEISS Ventures as part of a financing round. The biotechnology firm will put this fresh capital towards the commercialization of its technology for 3D microtissues and will seek to establish the world’s largest biobank for pharmaceutical research.
UZH researchers develop innovative light microscope
Zurich - Researchers from the University of Zurich (UZH) have developed an innovative objective for light microscopy. Instead of several lenses, it uses a mirror and a single corrective lens. This objective is more cost-effective and can be more widely used than conventional equivalents.

Meet with an expansion expert

Our services are free of charge and include:

  • Introduction to key contacts in industry, academia, and government
  • Advice on regulatory framework, taxes, labor, market, and setting up a company
  • Custom-made fact-finding visits, including office and co-working space